Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katsufumi Mizushige

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Current Vascular Pharmacology|February 14, 2006
The effects of olprinone, a phosphodiesterase 3 inhibitor, on systemic and cerebral circulationTakashi Ueda, Katsufumi Mizushige
Cardiovascular Drug Reviews|December 14, 2002
Pioglitazone: cardiovascular effects in prediabetic patientsKatsufumi Mizushige, Teppei Tsuji, Takahisa Noma
Cardiovascular Drug Reviews|October 25, 2002
Olprinone: a phosphodiesterase III inhibitor with positive inotropic and vasodilator effectsKatsufumi Mizushige, Takashi Ueda, Kazushi Yukiiri, et al.
Internal Medicine (Tokyo, Japan)|March 5, 2011
Right pulmonary agenesis in an elderly woman complicated by transient ischemic attackTakashi Ueda, Masahiko Nozoe, Yasuhisa Nakamoto, et al.
Angiology|February 5, 2004
Left atrial thrombosis in achalasia--a case reportTakashi Ueda, Katsufumi Mizushige, Keishi Ueda, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 27, 2003
New index for grading the severity of aortic regurgitation based on the cross-sectional area of vena contracta measured by color Doppler flow mappingShiro Nozaki, Katsufumi Mizushige, Tomohiko Taminato, et al.
Journal of Nutritional Science and Vitaminology|May 9, 2007
Inhibitory effects of soy isoflavones on cardiovascular collagen accumulation in ratsTakafumi Mizushige, Katsufumi Mizushige, Akira Miyatake, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 18, 2003
Improvement of cerebral blood flow by olprinone, a phosphodiesterase-3 inhibitor, in mild heart failureTakashi Ueda, Katsufumi Mizushige, Kazushi Yukiiri, et al.
Heart and Vessels|September 5, 2003
Atrial fibrillation induced by simvastatin treatment in a 61-year-old manTakemi Akahane, Katsufumi Mizushige, Hatsumi Nishio, et al.
Clinical Neurology and Neurosurgery|August 7, 2004
The cerebrovascular dilatation effects of olprinone, a phosphodiesterase III inhibitor, in comparison with acetazolamide--a pilot studyTakashi Ueda, Katsufumi Mizushige, Kazushi Yukiiri, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Current Vascular Pharmacology|February 14, 2006
The effects of olprinone, a phosphodiesterase 3 inhibitor, on systemic and cerebral circulationTakashi Ueda, Katsufumi Mizushige
Cardiovascular Drug Reviews|December 14, 2002
Pioglitazone: cardiovascular effects in prediabetic patientsKatsufumi Mizushige, Teppei Tsuji, Takahisa Noma
Cardiovascular Drug Reviews|October 25, 2002
Olprinone: a phosphodiesterase III inhibitor with positive inotropic and vasodilator effectsKatsufumi Mizushige, Takashi Ueda, Kazushi Yukiiri, et al.
Internal Medicine (Tokyo, Japan)|March 5, 2011
Right pulmonary agenesis in an elderly woman complicated by transient ischemic attackTakashi Ueda, Masahiko Nozoe, Yasuhisa Nakamoto, et al.
Angiology|February 5, 2004
Left atrial thrombosis in achalasia--a case reportTakashi Ueda, Katsufumi Mizushige, Keishi Ueda, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 27, 2003
New index for grading the severity of aortic regurgitation based on the cross-sectional area of vena contracta measured by color Doppler flow mappingShiro Nozaki, Katsufumi Mizushige, Tomohiko Taminato, et al.
Journal of Nutritional Science and Vitaminology|May 9, 2007
Inhibitory effects of soy isoflavones on cardiovascular collagen accumulation in ratsTakafumi Mizushige, Katsufumi Mizushige, Akira Miyatake, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 18, 2003
Improvement of cerebral blood flow by olprinone, a phosphodiesterase-3 inhibitor, in mild heart failureTakashi Ueda, Katsufumi Mizushige, Kazushi Yukiiri, et al.
Heart and Vessels|September 5, 2003
Atrial fibrillation induced by simvastatin treatment in a 61-year-old manTakemi Akahane, Katsufumi Mizushige, Hatsumi Nishio, et al.
Clinical Neurology and Neurosurgery|August 7, 2004
The cerebrovascular dilatation effects of olprinone, a phosphodiesterase III inhibitor, in comparison with acetazolamide--a pilot studyTakashi Ueda, Katsufumi Mizushige, Kazushi Yukiiri, et al.
Pageof 5